Lincoln Pharmaceuticals consolidated net profit declines 25.93% in the December 2024 quarter
Sales rise 0.07% to Rs 146.55 crore
Net profit of Lincoln Pharmaceuticals declined 25.93% to Rs 20.77 crore in the quarter ended December 2024 as against Rs 28.04 crore during the previous quarter ended December 2023. Sales rose 0.07% to Rs 146.55 crore in the quarter ended December 2024 as against Rs 146.45 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales146.55146.45 0 OPM %16.1420.25 -PBDT31.9140.52 -21 PBT28.6837.71 -24 NP20.7728.04 -26Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content